Amedes Group signs DNA testing licensing agreement with Chronix Biomedical Inc.

Chronix Biomedical: Study Results on Cell-Free DNA Test for Kidney Transplantation Presented at AACC

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response to Immunotherapy

Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response in Metastatic Cancers

Chronix Biomedical to Present Clinical Data on Its Cell-Free DNA Approach as an Early Predictor of Response to Chemotherapy at the AACR Annual Meeting

Chronix Biomedical Files Patent Application on Liquid Biopsy

Chronix Biomedical AACR Investor Press Release